Ricardo Rezola
- Cancer Research top 10%
- Breast Cancer Treatment Studies 6
- Oncology top 10%
- Cancer Cells and Metastasis 3
- Cytokine Signaling Pathways and Interactions 2
- HER2/EGFR in Cancer Research 2
-
- Epigenetics and DNA Methylation 2
- Otorhinolaryngology top 10%
-
- Breast Lesions and Carcinomas 4
-
- Advanced Breast Cancer Therapies 2
-
- Estrogen and related hormone effects 2
- Co-authors
- Kepa ElorriagaÁngel G. MartínAtanasio PandiellaErika López‐ArribillagaSusana Hernández-GarcíaOlatz LeisMarian M. de PancorboNaiara G. Bediaga
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Ricardo Rezola
16 papers receiving 775 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 287
- Oncology 354
- Molecular Biology 517
- Otorhinolaryngology 23
- Pathology and Forensic Medicine 79
Countries citing papers authored by Ricardo Rezola
This map shows the geographic impact of Ricardo Rezola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Rezola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Rezola more than expected).
Fields of papers citing papers by Ricardo Rezola
This network shows the impact of papers produced by Ricardo Rezola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Rezola. The network helps show where Ricardo Rezola may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ricardo Rezola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 15 | |
| 2 | 2019 | 1 | |
| 3 | 2018 | 0 | |
| 4 | 2017 | 3 | |
| 5 | 2016 | 13 | |
| 6 | 2015 | 1 | |
| 7 | 2013 | 21 | |
| 8 | 2012 | 11 | |
| 9 | 2012 | 1 | |
| 10 | 2011 | 427 | |
| 11 | 2011 | 55 | |
| 12 | 2010 | 142 | |
| 13 | 2003 | 59 | |
| 14 | 2002 | 14 | |
| 15 | Aplicaciones de una mesa de estereotaxia digital en el diagnóstico de lesiones mamarias no palpables: presentación de nuestra experiencia | 2000 | 2 |
| 16 | 1997 | 27 | |
| 17 | [Effect of diagnosis and treatment of digestive candidiasis on the incidence at autopsy of systemic candidiasis in patients with acute leukemia and hypoplastic pancytopenia]. | 1982 | 1 |
About Ricardo Rezola
Ricardo Rezola is a scholar working on Cancer Research, Oncology and Otorhinolaryngology, having authored 17 papers that have together received 793 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers), Cancer Cells and Metastasis (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Advanced Breast Cancer Therapies (2 papers), Epigenetics and DNA Methylation (2 papers), Estrogen and related hormone effects (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (287 citations), Oncology (354 citations) and Molecular Biology (517 citations). Ricardo Rezola has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Kepa Elorriaga, Ángel G. Martín, Atanasio Pandiella, Erika López‐Arribillaga, Susana Hernández-García, Olatz Leis, Marian M. de Pancorbo, Naiara G. Bediaga, Isabel Guerra and Mario F. Fraga. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.